MDLinx Neuro Brief

A breakthrough blood test for brain tumors, 10x sensitivity for Alzheimer’s detection, and how coffee can save your brain

Beating a neurological disease—especially the degenerative kind—comes down to getting ahead of it. This week, we’re getting a whole lot closer to that lofty goal thanks to two new tests—one for Alzheimer’s and one for Parkinson’s—that each boast tenfold increases in sensitivity. Plus, we’ve got new neurological benefits of coffee, a debunked link between cannabis…

Dangerous effects of hypertension on neuro patients, a common neurological condition is often misdiagnosed, and a natural hormone could predict Alzheimer’s

As flu season ramps up, everyone’s keeping their eyes on COVID-19 numbers, especially patients with neurologic disease and the doctors who treat them. Every day our understanding of how the pandemic impacts these patients becomes clearer, and the image is pretty scary—fitting for the Halloween season. This week we offer insights into how the pandemic…

Approved neuro drugs could have deadly consequences, genetic variation linked to cognitive decline, and new Alzheimer’s biomarker key to early detection

World Alzheimer’s Day arrived last week and brought with it a host of new research into the world’s most common form of dementia. We’re celebrating with an influx of new dementia insights, including the condition’s ancient history, two new cutting-edge biomarkers, and a pandemic-related condition that doubles its risk. Plus, shocking new data on your…

×